O
Omnix Medical
Omnix Medical is a clinical-stage biopharmaceutical company developing next-generation of anti-infective drugs to overcome the threat of Antimicrobial Resistance
About Omnix Medical
Developer of an antimicrobial drug technology designed to develop and commercialize highly effective antibiotic agents. The company's technology develops antibiotics for the treatment of life-threatening infections involving multi-drug resistant bacteria, enabling pharmaceutical clients to provide a cure for people who suffer from infections associated with resistant bacteria.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 26
- Open positions
- None listed
- Dealroom signal
- 76.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Spinout, EIC, Biotech and Pharma, EIC Fund, Horizon Europe, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jul 2026 | $8.8M | — | European Innovation Council · Horizon Europe | ↗ |
| SERIES C✓Equity / VC | Oct 2025 | $25M | $100M | Xenia Venture Capital · Entrée Capital · OurCrowd · Tal Ventures | ↗ |
Growth signals
Latest recorded traffic for Omnix Medical is 1.1K monthly website visits, up 1122.2% over the last three months. Omnix Medical's team grew 4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Omnix Medical in the Jerusalem ecosystem
The Omnix Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
European Innovation Council
Tal Ventures
Horizon Europe
Series A2 investors entered at this stage
EIC Fund
Entrée Capital
Series B and later4 investors entered at this stage
Harel Group
Xenia Venture Capital
OurCrowd
Prevail Partners
Other known investors3 additional known investors
The Hebrew University of Jerusalem- DMDocor International Management
VLX Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Omnix Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Omnix Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








